Effect of dilution rate on productivity of continuous bacteriophage production in cellstat
- 199 Downloads
Ability to efficiently propagate high quantities of bacteriophages (phages) is of great importance considering higher phage production needs in the future. Continuous production of phages could represent an interesting option. In our study, we tried to elucidate the effect of dilution rate on productivity of continuous production of phages in cellstat. As a model system, a well-studied phage T4 and Escherichia coli K-12 as a host were used. Experiments where physiology of bacteria was changing with dilution rate of cellstat and where bacterial physiology was kept constant were performed. For both setups there exists an optimal dilution rate when maximal productivity is achieved. Experimentally obtained values of phage concentration and corresponding productivity were compared with mathematical model predictions, and good agreement was obtained for both types of experiments. Analysis of mathematical model coefficients revealed that latent period and burst size to dilution rate coefficient mostly affect optimum dilution rate and productivity. Due to high sensitivity, it is important to evaluate phage growth parameters carefully, to run cellstat under optimal productivity.
KeywordsPhage T4 E. coli K-12 Cellstat Continuous production Productivity
This study was funded by Slovenian Research Agency—ARRS (research program no. P3-0387, project no. L4-5532, and project no. 3030-37543). The study was also supported by the European Regional Development Fund and Slovenian Ministry of Education, Science and Sport (project BioPharm.Si).
Compliance with ethical standards
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest.
- Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B, Delattre A-S, Lavigne R (2012) Learning from bacteriophages—advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci 13:699–722. https://doi.org/10.2174/138920312804871193 CrossRefPubMedPubMedCentralGoogle Scholar
- Golec P, Karczewska-Golec J, Łoś M, Węgrzyn G (2014) Bacteriophage T4 can produce progeny virions in extremely slowly growing Escherichia coli host: comparison of a mathematical model with the experimental data. FEMS Microbiol Lett 351:156–161. https://doi.org/10.1111/1574-6968.12372 CrossRefPubMedGoogle Scholar
- Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H, Horiuchi T (2006) Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol 2:2006.0007. doi: https://doi.org/10.1038/msb4100049
- Kropinski AM, Mazzocco A, Waddell TE, Lingohr E, Johnson RP (2009) Enumeration of bacteriophages by double agar overlay plaque assay. In: Clokie MRJ, Kropinski AM (eds) Bacteriophages. Methods in Molecular Biology™. Humana Press, New York, pp 69–76Google Scholar
- Kutter E, Kellenberger E, Carlson K, Eddy S, Neitzel J, Messinger L, North J, Guttman B (1994) Effects of bacterial growth conditions and physiology on T4 infection. In: Karam JD (ed) Molecular biology of bacteriophage T4. American Society for Microbiology, Washington, DC, pp 406–418Google Scholar
- Malik DJ, Sokolov IJ, Vinner GK, Mancuso F, Cinquerrui S, Vladisavljevic GT, Clokie MRJ, Garton NJ, Stapley AGF, Kirpichnikova A (2017) Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interfac 249:100–133. https://doi.org/10.1016/j.cis.2017.05.014 CrossRefGoogle Scholar
- Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, Glonti T, Krylov V, Mast J, Van Parys L, Lavigne R, Volckaert G, Mattheus W, Verween G, De Corte P, Rose T, Jennes S, Zizi M, De Vos D, Vaneechoutte M (2009) Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 4:e4944. https://doi.org/10.1371/journal.pone.0004944 CrossRefPubMedPubMedCentralGoogle Scholar
- Nobrega FL, Costa AR, Santos JF, Siliakus MF, van Lent JWM, Kengen SWM, Azeredo J, Kluskens LD (2016) Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine. Sci Rep 6:39235. https://doi.org/10.1038/srep39235 CrossRefPubMedPubMedCentralGoogle Scholar
- Pirnay JP, Blasdel BG, Bretaudeau L, Buckling A, Chanishvili N, Clark JR, Corte-Real S, Debarbieux L, Dublanchet A, De Vos D, Gabard J, Garcia M, Goderdzishvili M, Górski A, Hardcastle J, Huys I, Kutter E, Lavigne R, Merabishvili M, Olchawa E, Parikka KJ, Patey O, Pouilot F, Resch G, Rohde C, Scheres J, Skurnik M, Vaneechoutte M, Van Parys L, Verbeken G, Zizi M, Van den Eede G (2015) Quality and safety requirements for sustainable phage therapy products. Pharm Res 32:2173–2179. https://doi.org/10.1007/s11095-014-1617-7 CrossRefPubMedPubMedCentralGoogle Scholar
- Podgornik A, Janež N, Smrekar F, Peterka M (2014) Continuous production of bacteriophages. In: Subramanian G (ed) Continuous processing in pharmaceutical manufacturing. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, pp 297–338Google Scholar
- Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heure OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain J-M, Segovia C, Sigauque B, Taconelli E, Wellington E, Vila J (2015) The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect 6:22–29. https://doi.org/10.1016/j.nmni.2015.02.007 CrossRefPubMedPubMedCentralGoogle Scholar
- Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring HarborGoogle Scholar
- Simmons LA, Foti JJ, Cohen SE, Walker GC (2008) The SOS Regulatory Network. EcoSal Plus 2008. doi: https://doi.org/10.1128/ecosalplus.5.4.3
- Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J, Infectious Diseases Society of America (2008) The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46:155–164. https://doi.org/10.1086/524891 CrossRefPubMedGoogle Scholar
- Wee S, Wilkinson BJ (1988) Increased outer membrane ornithine-containing lipid and lysozyme penetrability of Paracoccus denitrificans grown in a complex medium deficient in divalent cations. J Bacteriol 170:3283–3286. https://doi.org/10.1128/jb.170.7.3283-3286.1988 CrossRefPubMedPubMedCentralGoogle Scholar
- Ziv N, Brandt NJ, Gresham D (2013) The use of chemostats in microbial systems biology. J Vis Exp. https://doi.org/10.3791/50168